These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17938864)

  • 1. RNA interference (RNAi)-mediated vascular endothelial growth factor-C (VEGF-C) reduction interferes with lymphangiogenesis and enhances epirubicin sensitivity of breast cancer cells.
    Sun P; Gao J; Liu YL; Wei LW; Wu LP; Liu ZY
    Mol Cell Biochem; 2008 Jan; 308(1-2):161-8. PubMed ID: 17938864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
    Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
    Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNAi-mediated gene silencing of vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of gastric cancer in vivo in mice.
    Yao J; Da M; Guo T; Duan Y; Zhang Y
    Tumour Biol; 2013 Jun; 34(3):1493-501. PubMed ID: 23475632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference-mediated vascular endothelial growth factor-C reduction suppresses malignant progression and enhances mitomycin C sensitivity of bladder cancer T24 cells.
    Zhang HH; Qi F; Shi YR; Miao JG; Zhou M; He W; Chen MF; Li Y; Zu XB; Qi L
    Cancer Biother Radiopharm; 2012 Jun; 27(5):291-8. PubMed ID: 21902544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.
    Guo B; Zhang Y; Luo G; Li L; Zhang J
    Anat Rec (Hoboken); 2009 May; 292(5):633-9. PubMed ID: 19382240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between cyclooxygenase-2 and human epidermal growth factor receptor 2 in vascular endothelial growth factor C up-regulation and lymphangiogenesis in human breast cancer.
    Bhattacharjee RN; Timoshenko AV; Cai J; Lala PK
    Cancer Sci; 2010 Sep; 101(9):2026-32. PubMed ID: 20608938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of the correlation between HER-2 gene and lymphangiogenesis and their prognostic significance in human breast cancer].
    Zhang GH; Yang WT; Zhou XY; Zeng Y; Lu HF; Shi DR
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):155-60. PubMed ID: 17425844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer].
    Zheng SQ; Huang RQ; Zhang YJ
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):240-4. PubMed ID: 20654122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice.
    He XW; Yu X; Liu T; Yu SY; Chen DJ
    Chin Med J (Engl); 2008 Mar; 121(5):439-44. PubMed ID: 18364118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of short haipin RNA targeting vascular endothelial growth factor-C on biological characteristics of human breast cancer cell MCF-7].
    Xie XB; Long J; Yang F; Zhang YJ
    Zhonghua Bing Li Xue Za Zhi; 2009 Jul; 38(7):472-6. PubMed ID: 19781195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo.
    He XW; Liu T; Chen YX; Cheng DJ; Li XR; Xiao Y; Feng YL
    Cancer Gene Ther; 2008 Mar; 15(3):193-202. PubMed ID: 18202713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CPT1A regulates breast cancer-associated lymphangiogenesis via VEGF signaling.
    Xiong Y; Liu Z; Zhao X; Ruan S; Zhang X; Wang S; Huang T
    Biomed Pharmacother; 2018 Oct; 106():1-7. PubMed ID: 29940537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancer.
    Cai X; Ma S; Gu M; Zu C; Qu W; Zheng X
    Diagn Pathol; 2012 May; 7():52. PubMed ID: 22607367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNAi-mediated gene silencing of vascular endothelial growth factor C suppresses growth and induces apoptosis in mouse breast cancer
    Liu YC; Ma WH; Ge YL; Xue ML; Zhang Z; Zhang JY; Hou L; Mu RH
    Oncol Lett; 2016 Nov; 12(5):3896-3904. PubMed ID: 27895746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis.
    Ochi N; Matsuo Y; Sawai H; Yasuda A; Takahashi H; Sato M; Funahashi H; Okada Y; Manabe T
    Pancreas; 2007 May; 34(4):444-51. PubMed ID: 17446844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WISP-1 promotes VEGF-C-dependent lymphangiogenesis by inhibiting miR-300 in human oral squamous cell carcinoma cells.
    Lin CC; Chen PC; Lein MY; Tsao CW; Huang CC; Wang SW; Tang CH; Tung KC
    Oncotarget; 2016 Mar; 7(9):9993-10005. PubMed ID: 26824419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C/VEGFR-3 dependent PI3K/AKT pathway.
    Huang B; Lu Y; Gui M; Guan J; Lin M; Zhao J; Mao Q; Lin J
    Biomed Pharmacother; 2021 May; 137():111331. PubMed ID: 33578235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage migration inhibitory factor regulating the expression of VEGF-C through MAPK signal pathways in breast cancer MCF-7 cell.
    Zhang J; Zhang G; Yang S; Qiao J; Li T; Yang S; Hong Y
    World J Surg Oncol; 2016 Feb; 14():51. PubMed ID: 26911617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.